Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Ligand Pharmaceuticals
(LGND) Q2 2025
Earnings
LGND
May 8
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
1.06
1.32
1.58
1.84
Details
Expected EPS
1.211667
Actual EPS
1.33
Surprise EPS
0.12
Surprise Percent
+9.77%
Description
Ligand Pharmaceuticals (LGND) has reported earnings of 1.33 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login